Author:
Kubota Eiji,Dean Rachael G.,Hubner Richard A.,Balding Leanne C.,Johnston Colin I.,Burrell Louise M.
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Johnston CI, Hodsman PG, Kohzuki M, et al.: Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists. Am J Med 1989, 87:24S-28S.
2. Roques BP, Noble F, Dauge V, et al.: Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 1993, 45:118–146.
3. Levin ER, Gardner DG, Samson WK: Mechanisms of disease — natriuretic peptides. N Engl J Med 1998, 339:321–328.
4. Burnett JC Jr: Vasopeptidase inhibition: a new concept in blood pressure management. J Hypertens 1999, 17:S37-S43.
5. Weber M: Emerging treatments for hypertension: potential role for vasopeptidase inhibition. Am J Hypertens 1999, 12:139S-147S.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献